SBFM

Sunshine Biopharma
SBFM

Overview Fund Trends Analyst Outlook Journalist POV

11 hedge funds and large institutions have $152K invested in Sunshine Biopharma in 2025 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 3 increasing their positions, 1 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more capital invested

Capital invested by funds: $ → $

more ownership

Funds ownership: →

less funds holding

Funds holding: →

50% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 2

Holders
11
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$96.4K
2
+$36.3K
3
+$8.62K
4
National Bank of Canada
National Bank of Canada
Quebec, Canada
+$6

Top Sellers

1
-$34K
2
-$7.27K
3
-$12
Name Holding Trade Value Shares
Change 		Change in
Stake
ACM
1
Altium Capital Management
New York
$96.4K
UBS Group
2
UBS Group
Switzerland
$38K
SS
3
SBI Securities
Japan
$9.98K
Morgan Stanley
4
Morgan Stanley
New York
$7.32K
National Bank of Canada
5
National Bank of Canada
Quebec, Canada
$19
Bank of America
6
Bank of America
North Carolina
$10
RA
7
Rise Advisors
New York
$2
FFA
8
Farther Finance Advisors
California
$2
Osaic Holdings
9
Osaic Holdings
Arizona
$2
TWC
10
TD Waterhouse Canada
Ontario, Canada
$2
FDCDDQ
11
Federation des caisses Desjardins du Quebec
Quebec, Canada
$2
CCM
12
Connective Capital Management
California
–
Northwestern Mutual Wealth Management
13
Northwestern Mutual Wealth Management
Wisconsin
–